[1]
2019. Development and Evaluation of Lapatinib Solid Lipid Nanoparticles in the Management of Breast Cancer. International Journal of Pharmaceutical Sciences and Drug Research. 11, 5 (Sep. 2019), 245–249. DOI:https://doi.org/10.25004/IJPSDR.2019.110515.